Coordinator for multiple studies concerning rare genetic diseases. Responsibilities include but are not limited to conducting the informed consent process, screening subjects using protocol-specific inclusion/exclusion criteria, dispensing IDP and maintaining study drug use accountability, processing and shipping lab specimens, ensuring all data is collected as per protocol and transferred to EDCs, coordinating with home care nursing companies, submitting regulatory and ethical information to IRBs, maintaining regulatory study files, serving as point of contact for CRAs, participating in SIVs, COVs, and all interim monitoring visits, preparing and submitting quarterly invoices, scheduling subject visits and assessments both on- and off-site, monitoring and documenting patients’ adverse events, coordinating travel/hotel arrangements as well as stipend and reimbursement payments for subjects, creating source documents, writing and editing manuscripts for publication.

Responsible for coordinating several observational studies following GCP in maintaining accountability and integrity of clinical trial materials in accordance with FDA and IRB regulations, conducting the informed consent process, preparing source documents and laboratory requisition forms for visits, entering data from clinical assessments as well as results from various tests and procedures into EDCs, serving as point of contact for study monitors, submitting regulatory and ethical information to IRBs, keeping accurate records of entries for invoicing.

Conducted laboratory research to study the effect of immunological agents in mediating acute inflammation and subsequent behavioral outcomes following spinal cord injury. Utilized various techniques including PCR, immunohistochemistry, and behavioral observation; data collection, analysis, and presentation.

Utilized patch-clamp technique to study taste receptor cell signal transduction in response to chemical stimuli. Recorded and graphed data.

Carried out research to determine the efficacy of pharmacologic agents on muscle spasticity and neuropathic pain resulting from chronic traumatic spinal cord injury. Performed stereotaxic surgery, testing, data recording and statistical analysis; written and oral presentations.

Conducted experiments to study the differential effects of pharmacological agents in mediating aspects of pain and drug tolerance in hibernating and non-hibernating phases. Performed stereotaxic surgery, testing, data collection and analysis; written and oral presentations.